MTOR and cancer: As PI3K-Akt-mTOR pathway has dual effect on chemosensitivity in cancer cells [24–26], activity of PI3K-Akt-mTOR pathway in response to cisplatin or/and NVP-BEZ235 in U2OS and Saos-2 cellscells were analyzed.